Australian biotech market today 18.03.09
Wednesday, 18 March, 2009
Pharma and biotech stocks were down slightly at 2.30pm today, on an up-and-down day for the All Ords.
Alchemia (ASX:ACL) is up yet again on the market today, trading at 32c and still basking in the washout from its partner filing a new drug application for generic fondaparinux.
Avexa (ASX:AVX) is down a touch from its recent gains, Biota (ASX:BTA) is up 5c to 61c and Cytopia (ASX:CYT) is up a cent.
Cochlear (ASX:COH) keeps rising and is now trading over $50 while CSL (ASX:CSL) is down a bit.
Newly listed Genera Biosystems (ASX:GBI) is active, up 2c, as is Halcygen (ASX:HGN).
Mesoblast (ASX:MSB) is down 2c, while Nanosonics (ASX:NAN) is up.
Universal Biosensors (ASX:UBI) is up 5c.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
